MME and nonpapillary renal cell carcinoma: Taken together, our results show that SR-B1 and CD10 immunoreactivity have higher sensitivity and specificity for ccRCC diagnosis, and can improve specificity when combined, even for identifying tumors with clear cell morphology (Fig. 3).